Literature DB >> 12751639

Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning.

Geert Verreck1, Iksoo Chun, Jef Peeters, Joel Rosenblatt, Marcus E Brewster.   

Abstract

PURPOSE: We assessed the application of water-soluble polymer-based nanofibers prepared by electrostatic spinning as a means of altering the dissolution rate of the poorly water-soluble drug, itraconazole.
METHODS: Organic solvent-based solutions of itraconazole/HPMC mixtures were electrostatically spun at 16 and 24 kV. The formed nanofibers were collected as a non-woven fabric. The samples were analyzed by scanning electron microscopy. differential scanning calorimetry, and dissolution rate.
RESULTS: Scanning electron microscopy showed fiber diameters of 1-4 microm and 300-500 nm depending on the applied voltage. Differential scanning calorimetry measurements found that the melting endotherm for itraconazole was not present, suggesting the formation of an amorphous solid dispersion or solution. Dissolution studies assessed several presentations including direct addition of the non-woven fabrics to the dissolution vessels, folding weighed samples of the materials into hard gelatin capsules and placing folded material into a sinker. Controls included a physical mixture as well as solvent cast and melt extruded samples. Electrospun samples dissolved completely over time with the rate of dissolution depending on the formulation presentation and drug to polymer ratio. The physical mixture did not appreciably dissolve in these conditions.
CONCLUSIONS: The application of electrostatic spinning to pharmaceutical applications resulted in dosage forms with useful and controllable dissolution properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751639     DOI: 10.1023/a:1023450006281

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

Authors:  A T Serajuddin
Journal:  J Pharm Sci       Date:  1999-10       Impact factor: 3.534

Review 2.  Itraconazole: an effective oral antifungal for onychomycosis.

Authors:  S Jain; V N Sehgal
Journal:  Int J Dermatol       Date:  2001-01       Impact factor: 2.736

Review 3.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 4.  Improving drug solubility for oral delivery using solid dispersions.

Authors:  C Leuner; J Dressman
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

Review 5.  DISSOLUTION RATES.

Authors:  D E WURSTER; P W TAYLOR
Journal:  J Pharm Sci       Date:  1965-02       Impact factor: 3.534

6.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).

Authors:  R A Prentis; Y Lis; S R Walker
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

7.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend.

Authors:  El-Refaie Kenawy; Gary L Bowlin; Kevin Mansfield; John Layman; David G Simpson; Elliot H Sanders; Gary E Wnek
Journal:  J Control Release       Date:  2002-05-17       Impact factor: 9.776

Review 8.  Pharmacology of itraconazole.

Authors:  K De Beule; J Van Gestel
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 9.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

10.  Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.

Authors:  Jef Peeters; Peter Neeskens; Jan P Tollenaere; Pieter Van Remoortere; Marcus E Brewster
Journal:  J Pharm Sci       Date:  2002-06       Impact factor: 3.534

  10 in total
  30 in total

1.  Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.

Authors:  Adam Bohr; Jakob Kristensen; Mark Dyas; Mohan Edirisinghe; Eleanor Stride
Journal:  J R Soc Interface       Date:  2012-04-25       Impact factor: 4.118

2.  Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug.

Authors:  Deng-Guang Yu; Li-Dong Gao; Kenneth White; Christopher Branford-White; Wei-Yue Lu; Li-Min Zhu
Journal:  Pharm Res       Date:  2010-08-19       Impact factor: 4.200

Review 3.  Recent development of polymer nanofibers for biomedical and biotechnological applications.

Authors:  Yanzhong Zhang; Chwee Teck Lim; Seeram Ramakrishna; Zheng-Ming Huang
Journal:  J Mater Sci Mater Med       Date:  2005-10       Impact factor: 3.896

4.  Monitoring tablet surface roughness during the film coating process.

Authors:  Paulus Seitavuopio; Jyrki Heinämäki; Jukka Rantanen; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2006-04-07       Impact factor: 3.246

Review 5.  The role of electrospinning in the emerging field of nanomedicine.

Authors:  S Y Chew; Y Wen; Y Dzenis; K W Leong
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 6.  Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration.

Authors:  Robert L Mauck; Brendon M Baker; Nandan L Nerurkar; Jason A Burdick; Wan-Ju Li; Rocky S Tuan; Dawn M Elliott
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

Review 7.  Electrospun nanofibers in oral drug delivery.

Authors:  Francis Ignatious; Linghong Sun; Chao-Pin Lee; John Baldoni
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

8.  Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.

Authors:  Deng-Guang Yu; Christopher Branford-White; Kenneth White; Xue-Lian Li; Li-Min Zhu
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

Review 9.  Nanoparticles and nanofibers for topical drug delivery.

Authors:  Ritu Goyal; Lauren K Macri; Hilton M Kaplan; Joachim Kohn
Journal:  J Control Release       Date:  2015-10-28       Impact factor: 9.776

10.  Preparation of electrospun polyurethane nanofiber mats for the release of doxorubicine.

Authors:  Esra Kiliç; Arzu Yakar; Nursel Pekel Bayramgil
Journal:  J Mater Sci Mater Med       Date:  2017-12-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.